Extraordinary General Meeting at Meda

Extraordinary General Meeting at Meda At the extraordinary general meeting at Meda AB on Tuesday, 10 August 1999, Karl Perlhagen and Lennart Perlhagen were elected as members of the board. Staffan Edén and Lars Ingelmark had resigned from the board at an earlier stage than planned. At the subsequent board meeting following election, Per Carendi was elected as chairman of the board. For further information, please contact Göran Pettersson Managing DirectorPhone +46 31-701 28 01 or +46 70-445 03 01 Annette Johansson Public Relations Manager Phone +46 31-701 29 04 or +46 70-445 03 00 Meda develops profitable partnerships in the Nordic and Baltic areas in collaboration with international producers of pharmaceuticals, nutrition and medical device products. With our thorough knowledge and our expertise in marketing and sales, we offer benefits to the health and medical care sector at the same time as we promote our own and our partner's growth and development. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/08/11/19990811BIT00340/bit0001.pdf http://www.bit.se/bitonline/1999/08/11/19990811BIT00340/bit0002.doc

About Us

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.